ArticleThe Journal of international medical research2025
Risk model for depression in patients with chronic prostatitis/chronic pelvic pain syndrome: A retrospective cross-sectional study.
Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial Intelligence in the Assessment of Males with Chronic Pelvic Pain Syndrome: An Up-to-Date UPOINTS-Based Narrative Mapping Review.Diagnostics (Basel, Switzerland) · 2026Review
- Letter to the editor: "Clinical efficacy of ozone therapy in managing category IIIB chronic prostatitis: symptom improvement and antioxidant effects".World journal of urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThe correlation between depression and prostatitis is widely acknowledged; however, there is a dearth of comprehensive risk models that can predict the risk of depression in patients with chronic prostatitis/chronic pelvic pain syndrome. In this investigation, we devised a predictive model to ascertain the likelihood of depression in these patients.MethodsThis prospective study enrolled 599 patients with chronic prostatitis/chronic pelvic pain syndrome between January 2022 and January 2025. The patients were randomly divided into training (70%, n = 419) and validation (30%, n = 180) cohorts. Using depression (Patient Health Questionnaire-9 score ≥10) as the primary outcome, we developed a nomogram using Boruta and least absolute shrinkage and selection operator feature selection followed by multivariate logistic regression. Model performance was assessed using receiver operating characteristic curve analysis (area under the receiver operating characteristic curve), calibration plots, and decision curve analysis, with internal validation performed in the validation cohort.ResultsThe nomogram integrated seven readily available predictors (prostate progression, hypertension, International Prostate Symptom Score, number of nights with sleep disturbance, white blood cell count, triglyceride level, and hemoglobin level) and showed excellent performance (area under the receiver operating characteristic curve values = 0.864 in the training cohort and 0.911 in the validation cohort).DiscussionThis nomogram can help urologists quickly identify chronic prostatitis/chronic pelvic pain syndrome patients at high risk of depression, enable early psychological intervention, and improve the quality of life of these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.